AbbVie Stock Is Quietly Exploding on New Drug Hype – Are You Late?
AbbVie Inc. shares have jumped 12% in the past month amid investor excitement over its obesity treatments, cancer therapies and immunology drugs. Wall Street analysts point to strong cash flow and new drug approvals as key drivers behind the rally.